<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Continuity of Care Document</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Continuity of Care Document</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">LUCIA ROMAN</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">November 4, 1947 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Home Address:<br/>6875 W FLAGLER ST APT 206<br/>MIAMI, FL 33144, US<br/><br/> Home Address:<br/>6875 W FLAGLER ST APT 205<br/>MIAMI, FL 33144<br/>Expiration Date: October 11, 2024, 00:00:00  <br/><br/><br/>Primary Home Phone:  +1-(786)370-9395<br/>Email:  NONE<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">D794929 2.16.840.1.113883.3.1110.6.1.6.1.8.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">690a564b-93a1-4d5c-bed5-d8250727a83a 2.16.840.1.113883.3.1110</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">April 7, 2025, 18:54:51 +0000 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">KNOW DOES NOT </td></tr><tr><td class="td_header_role_value internal_format"/></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Otero Leandro L MD </td></tr><tr><td class="td_header_role_value internal_format"/></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Saad Amado </td></tr><tr><td class="td_header_role_value internal_format"/></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Saad De La Torre Amado MD </td></tr><tr><td class="td_header_role_value internal_format"/></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Liu Nathan MD </td></tr><tr><td class="td_header_role_value internal_format"/></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Szomstein Marcos X MD </td></tr><tr><td class="td_header_role_value internal_format"/></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">MIGUEL RODRIGUEZ GARCIA </td></tr><tr><td class="td_header_role_value internal_format">9971 W FLAGLER ST,MIAMI,FL,33174-1810<br/><br/><br/>Work Phone:  +1-(305)222-8335<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">INFCE </td></tr><tr><td class="td_header_role_value internal_format"/></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">RODRIGUEZ GARCIA MIGUEL ANGEL </td></tr><tr><td class="td_header_role_value internal_format"/></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">dbMotion 1.0.0.0</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Home Address:<br/>1 Park Plaza<br/>Nashville, TN 37203, US<br/><br/>Tel:  +1-(615)344-9551<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Information recipient:</span></td><td class="td_header_role_value">HCA HealthCare. If additional information is needed, contact Health Information Management at (844) 481-0278 or at PARA.HSC.MEDRECROIFAX@PARALLON.COM</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Home Address:<br/>1 Park Plaza<br/>Nashville, TN 37203, US<br/><br/>Tel:  +1-(615)344-9551<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">HCA HealthCare. If additional information is needed, contact Health Information Management at (844) 481-0278 or at PARA.HSC.MEDRECROIFAX@PARALLON.COM</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Home Address:<br/>1 Park Plaza<br/>Nashville, TN 37203, US<br/><br/>Tel:  +1-(615)344-9551<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Problems</a></li><li><a href="#id2">Allergies and Adverse Reactions</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Procedures</a></li><li><a href="#id5">Social History</a></li><li><a href="#id6">Results</a></li><li><a href="#id7">Vital Signs</a></li><li><a href="#id8">Encounters</a></li><li><a href="#id9">Plan of Treatment</a></li><li><a href="#id10">Health Concerns</a></li><li><a href="#id11">Goals</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Medical Equipment</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Problems</a></h3><div><table><colgroup><col width="40%"/><col width="20%"/><col width="40%"/></colgroup><tbody class="xRowGroup"><tr ID="_ef01fc21-a3fc-43f1-bd76-259e6b77d885"><td><span class="content_span">Type 2 diabetes mellitus with diabetic nephropathy</span><br/></td><td/><td/></tr></tbody><tbody class="xRowGroup"><tr ID="_156852aa-31f3-4a19-8a9e-c218a336546b"><td><span class="content_span">Essential (primary) hypertension</span><br/></td><td/><td/></tr></tbody><tbody class="xRowGroup"><tr ID="_594ceae9-5316-4dae-81c0-cfea4737a6f8"><td><span class="content_span">Other hyperlipidemia</span><br/></td><td/><td/></tr></tbody></table></div><h3><a name="id2" href="#toc">Allergies and Adverse Reactions</a></h3><div><table><colgroup><col width="40%"/><col width="20%"/><col width="40%"/></colgroup><tbody><tr ID="_68035f3a-45db-4536-8262-c4964931322e"><td><span class="content_span">iodine</span><span class="content_span"> (</span><span class="xSecondary">Allergy</span><span class="content_span">)</span><br/></td><td><span class="xSecondary">Onset: 11-Oct-2024</span></td><td><content><span class="xLabel xSecondary">Reaction: </span><content><span class="content_span">RASH</span></content></content></td></tr><tr ID="_61872bfb-c881-4a90-bf6f-eb0cf9c0d29e"><td><span class="content_span">iodine</span><span class="content_span"> (</span><span class="xSecondary">Allergy</span><span class="content_span">)</span><br/></td><td/><td/></tr></tbody></table></div><h3><a name="id3" href="#toc">Medications</a></h3><div><table><colgroup><col width="40%"/><col width="20%"/><col width="40%"/></colgroup><tbody class="xRowGroup"><tr ID="_b1de87b7-b243-412b-8d8a-d1ac35bf5701"><td><content class="xContentWrapping"><span class="content_span">1 ML HYDROmorphone hydrochloride 1 MG/ML Injection</span><span class="xLabel">; </span><span class="xSecondary">0.5 MILLIGRAM  PACU</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">Liu Nathan MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
To be given if patient is unable to swallow or has
nausea/vomiting</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_1810b656-b17b-4f9a-b206-c7221229b91b"><td><content class="xContentWrapping"><span class="content_span">2 ML fentaNYL 0.05 MG/ML Injection</span><span class="xLabel">; </span><span class="xSecondary">25 MICROGRAM  PACU</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">Liu Nathan MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
To be given if patient is unable to swallow or has
nausea/vomiting</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_af6fc241-d0c1-4407-8428-f6d8f7518bda"><td><content class="xContentWrapping"><span class="content_span">2 ML fentaNYL 0.05 MG/ML Injection</span><span class="xLabel">; </span><span class="xSecondary">50 MICROGRAM  PACU</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">Liu Nathan MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
To be given if patient is unable to swallow or has
nausea/vomiting</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_b96940bb-5c04-42d1-b2f6-a7222190fb66"><td><content class="xContentWrapping"><span class="content_span">1 ML naloxone hydrochloride 0.4 MG/ML Injection</span><span class="xLabel">; </span><span class="xSecondary">0.4 MILLIGRAM  PACU</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">Liu Nathan MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_e22bf0cf-8d12-42b8-a6e3-8dd80feec759"><td><content class="xContentWrapping"><span class="content_span">oxyCODONE hydrochloride 5 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">5 MILLIGRAM  PACU</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">Liu Nathan MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
MAY GIVE 1 DOSE EVERY 6 HOURS</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_4244846f-41cc-40f7-b705-482069cd3f4e"><td><content class="xContentWrapping"><span class="content_span">neostigmine methylsulfate 1 MG/ML Injectable Solution</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_ebef8e17-083e-4c07-bc59-0559d9035244"><td><content class="xContentWrapping"><span class="content_span">rocuronium bromide 10 MG/ML Injectable Solution</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_8ce0b126-c803-4eb1-946d-b67d2811a813"><td><content class="xContentWrapping"><span class="content_span">succinylcholine chloride 20 MG/ML Injectable Solution [Quelicin]</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_e0b236ec-987e-4703-bd8e-2ed4978d34e6"><td><content class="xContentWrapping"><span class="content_span">100 ML propofol 10 MG/ML Injection</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_4c7750cc-b6f5-4563-acea-59dc48178477"><td><content class="xContentWrapping"><span class="content_span">midazolam 1 MG/ML Injectable Solution</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_c8b8f2ef-3766-4cdd-a537-5693f418ed19"><td><content class="xContentWrapping"><span class="content_span">2 ML fentaNYL 0.05 MG/ML Injection</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_0653ea6c-185e-4919-9a4b-b147fb58f9e6"><td><content class="xContentWrapping"><span class="content_span">lidocaine hydrochloride 10 MG/ML Injectable Solution</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_b7c94601-e1c9-46ba-a233-30f991170e09"><td><content class="xContentWrapping"><span class="content_span">polymyxin B 250000 UNT/ML Injectable Solution</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_08760e86-c73b-4beb-89a6-49479d68ff02"><td><content class="xContentWrapping"><span class="content_span">gabapentin 100 MG Oral Capsule [Neurontin]</span><span class="xLabel">; </span><span class="xSecondary">Provider Administration Instructions:
**DO NOT CRUSH OR OPEN, SWALLOW WHOLE**</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">Provider Administration Instructions:
**DO NOT CRUSH OR OPEN, SWALLOW WHOLE**</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_38f14003-aa71-4401-93a2-4c2de0e544a1"><td><content class="xContentWrapping"><span class="content_span">acetaminophen 325 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">Provider Administration Instructions:
WATCH FOR ADDED ACETAMINOPHEN INTAKE, MAX OF 4 GRAMS/DAY.
NON-NARCOTIC ANALGESIC
SE: STOMACH UPSET   RASH</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">15-Oct-2024</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">Provider Administration Instructions:
WATCH FOR ADDED ACETAMINOPHEN INTAKE, MAX OF 4 GRAMS/DAY.
NON-NARCOTIC ANALGESIC
SE: STOMACH UPSET   RASH</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_148a3216-1686-4368-892e-05d70833a18c"><td><content class="xContentWrapping"><span class="content_span">amoxicillin 875 MG / clavulanate 125 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">amoxicillin-pot clavulanate</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">14 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">27-May-2024</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">amoxicillin-pot clavulanate</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_be2a07a5-4d85-408d-a630-98c780440242"><td><content class="xContentWrapping"><span class="content_span">benzonatate 100 MG Oral Capsule</span><span class="xLabel">; </span><span class="xSecondary">benzonatate</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">21 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">27-May-2024</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">benzonatate</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_ce7f2071-b5d7-4ea8-9c78-a4d3b3ae4493"><td><content class="xContentWrapping"><span class="content_span">gabapentin</span><span class="xLabel">; </span><span class="xSecondary">gabapentin</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">90 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">19-Jan-2024</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">gabapentin</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_a8ad013e-e7b7-496a-996d-97973e2b6f1e"><td><content class="xContentWrapping"><span class="content_span">amlodipine besylate</span><span class="xLabel">; </span><span class="xSecondary">amlodipine besylate</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">90 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">9-Jan-2024</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">amlodipine besylate</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_cfef4f34-a7f6-4ac8-9ab3-805a5a1c8c43"><td><content class="xContentWrapping"><span class="content_span">FeroSul</span><span class="xLabel">; </span><span class="xSecondary">FeroSul</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">24 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">18-Dec-2023</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">FeroSul</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_d68c8813-d02e-4880-93c3-495678e5a9c2"><td><content class="xContentWrapping"><span class="content_span">Januvia</span><span class="xLabel">; </span><span class="xSecondary">Januvia</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">90 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">10-May-2023</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">Januvia</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_972e1627-33f8-4c59-8eaf-43c1cf1f72dd"><td><content class="xContentWrapping"><span class="content_span">acetaminophen 325 MG / oxyCODONE hydrochloride 5 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">1 TABLET ORAL Q4H PRN</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">23-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">1 TAB PO Q4H PRN As Needed for BREAKTHROUGH PAIN</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_57cce03a-7e98-4cb5-9ac4-dbcedd5f7fb9"><td><content class="xContentWrapping"><span class="content_span">clonazePAM 0.5 MG Oral Tablet [KlonoPIN]</span><span class="xLabel">; </span><span class="xSecondary">0.5 MILLIGRAM ORAL HS</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">0.5 MG PO HS</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_22de8949-0e71-4acc-8aac-d8c790b82e5c"><td><content class="xContentWrapping"><span class="content_span">gabapentin 400 MG Oral Capsule [Neurontin]</span><span class="xLabel">; </span><span class="xSecondary">400 MILLIGRAM ORAL HS</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">400 MG PO HS</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_1fff873e-6b8c-4d3e-893c-36f6de5f5267"><td><content class="xContentWrapping"><span class="content_span">PARoxetine hydrochloride 20 MG Oral Tablet [Paxil]</span><span class="xLabel">; </span><span class="xSecondary">20 MILLIGRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">20 MG PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_402e1e27-a5bb-4a91-b55b-738825eb1208"><td><content class="xContentWrapping"><span class="content_span">atenolol 25 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">25 MILLIGRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">25 MG PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_d93dac1b-1e03-4a5a-a90b-82f46f327133"><td><content class="xContentWrapping"><span class="content_span">memantine hydrochloride 10 MG Oral Tablet [Namenda]</span><span class="xLabel">; </span><span class="xSecondary">10 MILLIGRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">10 MG PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_ab68ac27-736e-40f6-b3d1-1fd1669d2898"><td><content class="xContentWrapping"><span class="content_span">folic acid 1 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">1 MILLIGRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">1 MG PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_9caed17d-f6d0-4561-8f97-d159449e6221"><td><content class="xContentWrapping"><span class="content_span">famotidine 20 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">20 MILLIGRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">20 MG PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_cac97175-8a9d-48ed-938c-8a6abb0b3622"><td><content class="xContentWrapping"><span class="content_span">ubidecarenone 100 MG Oral Capsule</span><span class="xLabel">; </span><span class="xSecondary">100 MILLIGRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">100 MG PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_2193fa5e-101e-47fc-a396-26d17565edf0"><td><content class="xContentWrapping"><span class="content_span">metFORMIN hydrochloride 500 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">500 MILLIGRAM ORAL BID</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">500 MG PO BID</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_5b7148fe-fab2-4e29-a44f-704e2046f2b7"><td><content class="xContentWrapping"><span class="content_span">atorvastatin 10 MG Oral Tablet [Lipitor]</span><span class="xLabel">; </span><span class="xSecondary">10 MILLIGRAM ORAL AFTERNOON</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">10 MG PO AFTERNOON</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_1c10aeec-2772-4f7f-ae24-1f13438c6d5a"><td><content class="xContentWrapping"><span class="content_span">levothyroxine sodium 0.05 MG Oral Tablet [Synthroid]</span><span class="xLabel">; </span><span class="xSecondary">50 MICROGRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">50 MCG PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_cec865a8-3cd7-4cf4-8098-11e9f993f3da"><td><content class="xContentWrapping"><span class="content_span">PRINIZIDE 20-12.5 TABLET</span><span class="xLabel">; </span><span class="xSecondary">1 TABLET ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">1 TAB PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_ca3c49e9-aa7c-4fc2-87a8-a128840ceb98"><td><content class="xContentWrapping"><span class="content_span">Vitamin E 400 UNT Oral Capsule</span><span class="xLabel">; </span><span class="xSecondary">1 CAPSULE ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">22-Aug-2016</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">1 CAP PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_759afb33-1f27-4852-a295-db303185b398"><td><content class="xContentWrapping"><span class="content_span">lisinopril</span><span class="xLabel">; </span><span class="xSecondary">lisinopril</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">90 </span><br/></content></td><td/><td><span class="xLabel">Comments: </span><span class="xSecondary">lisinopril</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_4aa4f079-e845-45fd-8c82-108ae35cee70"><td><content class="xContentWrapping"><span class="content_span">Eliquis</span><span class="xLabel">; </span><span class="xSecondary">Eliquis</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">180 </span><br/></content></td><td/><td><span class="xLabel">Comments: </span><span class="xSecondary">Eliquis</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_7409d66c-cf76-4178-b66f-a65f8f2706c2"><td><content class="xContentWrapping"><span class="content_span">fluoxetine HCl</span><span class="xLabel">; </span><span class="xSecondary">fluoxetine HCl</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">30 </span><br/></content></td><td/><td><span class="xLabel">Comments: </span><span class="xSecondary">fluoxetine HCl</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_7be2f8ed-3eb4-4c36-ac16-ebb166ea6591"><td><content class="xContentWrapping"><span class="content_span">rosuvastatin calcium</span><span class="xLabel">; </span><span class="xSecondary">rosuvastatin calcium</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">90 </span><br/></content></td><td/><td><span class="xLabel">Comments: </span><span class="xSecondary">rosuvastatin calcium</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_214ec19c-6ff3-4a00-be1b-f77e8943001e"><td><content class="xContentWrapping"><span class="content_span">clonazepam</span><span class="xLabel">; </span><span class="xSecondary">clonazepam</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">30 </span><br/></content></td><td/><td><span class="xLabel">Comments: </span><span class="xSecondary">clonazepam</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_79bb0274-c8a4-465a-a121-039d58458a36"><td><content class="xContentWrapping"><span class="content_span">Creon</span><span class="xLabel">; </span><span class="xSecondary">Creon</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">90 </span><br/></content></td><td/><td><span class="xLabel">Comments: </span><span class="xSecondary">Creon</span></td></tr></tbody></table></div><h3><a name="id4" href="#toc">Procedures</a></h3><div><table><colgroup><col width="40%"/><col width="20%"/><col width="40%"/></colgroup><tbody class="xRowGroup"><tr ID="_d5851639-6544-4ae1-a69e-27b41382bbaa"><td><span class="content_span">IMPLANT NEUROELECTRODES</span></td><td><span class="xLabel xSecondary">Date: </span><span class="xSecondary">15-Oct-2024</span><br/></td><td/></tr></tbody><tbody class="xRowGroup"><tr ID="_d90efbec-effc-46be-8526-fcddd6860c6e"><td><span class="content_span">INSRT/REDO PN/GASTR STIMUL</span></td><td><span class="xLabel xSecondary">Date: </span><span class="xSecondary">15-Oct-2024</span><br/></td><td/></tr></tbody><tbody class="xRowGroup"><tr ID="_bed5ed0c-71f5-4068-94f3-91ab3d5fe4de"><td><span class="content_span">Prompt Pay Visit Tier 1</span></td><td><span class="xLabel xSecondary">Date: </span><span class="xSecondary">27-May-2024</span><br/></td><td><span class="xLabel xSecondary">Status: </span><span class="xSecondary">Completed</span><br/></td></tr></tbody></table></div><h3><a name="id5" href="#toc">Social History</a></h3><div><p>
    No Information
</p></div><h3><a name="id6" href="#toc">Results</a></h3><div><table><colgroup><col width="20%"/><col width="40%"/><col width="40%"/></colgroup><tbody class="xRowGroup"><tr><td><span class="xSecondary">Glucose by Monitoring Device</span></td><td><span class="xLabel">Ordered On: </span><span class="content_span">15-Oct-2024</span></td><td/></tr><tr ID="_a6472a8f-ebc2-41e5-a06e-838eb45e60b6"><td><span class="xSecondary xContentWrapping">15-Oct-2024 12:08</span></td><td><span class="xSecondary">Glucose by Monitoring Device</span><span class="xSecondary"> 82</span><span class="xSecondary"> mg/dL</span><span class="xSecondary"> (Normal)</span></td><td><content><span class="xLabel xSecondary">Range: </span><span class="xSecondary">70</span><span class="xSecondary"> mg/dL</span><span class="xSecondary"> - </span><span class="xSecondary">110</span><span class="xSecondary"> mg/dL</span><br/></content></td></tr></tbody><tbody class="xRowGroup"><tr><td><span class="xSecondary">Glucose by Monitoring Device</span></td><td><span class="xLabel">Ordered On: </span><span class="content_span">15-Oct-2024</span></td><td/></tr><tr ID="_85b81d2c-2233-4c2c-ac69-988ff48c922d"><td><span class="xSecondary xContentWrapping">15-Oct-2024 09:19</span></td><td><span class="xSecondary">Glucose by Monitoring Device</span><span class="xSecondary"> 91</span><span class="xSecondary"> mg/dL</span><span class="xSecondary"> (Normal)</span></td><td><content><span class="xLabel xSecondary">Range: </span><span class="xSecondary">70</span><span class="xSecondary"> mg/dL</span><span class="xSecondary"> - </span><span class="xSecondary">110</span><span class="xSecondary"> mg/dL</span><br/></content></td></tr></tbody><tbody class="xRowGroup"><tr><td><span class="xSecondary">Sofia 2 Flu + SARS Antigen FIA</span></td><td><span class="xLabel">Ordered On: </span><span class="content_span">27-May-2024</span></td><td/></tr><tr ID="_238e82cd-007b-47e1-99bd-e38f95b8d110"><td><span class="xSecondary xContentWrapping">27-May-2024 12:17</span></td><td><span class="xSecondary">FLUAV Ag IA.rapid Ql (Upper resp)</span><span class="xSecondary"> Negative</span><span class="xSecondary"> (Normal)</span></td><td><content><span class="xLabel xSecondary">Range: </span><span class="xSecondary"> Negative</span><br/></content></td></tr><tr ID="_9fe75d88-78a5-4aed-90a3-5964ede9a6a1"><td/><td><span class="xSecondary">FLUBV Ag IA.rapid Ql (Upper resp)</span><span class="xSecondary"> Negative</span><span class="xSecondary"> (Normal)</span></td><td><content><span class="xLabel xSecondary">Range: </span><span class="xSecondary"> Negative</span><br/></content></td></tr><tr ID="_c618b39f-896e-4dba-b037-5661a015efdb"><td/><td><span class="xSecondary">SARS-CoV-2 Result</span><span class="xSecondary"> Negative</span><span class="xSecondary"> (Normal)</span></td><td><content><span class="xLabel xSecondary">Range: </span><span class="xSecondary"> Negative</span><br/></content></td></tr></tbody></table></div><h3><a name="id7" href="#toc">Vital Signs</a></h3><div><table class="xBorderBottom"><colgroup><col width="40%"/><col width="20%"/><col width="40%"/></colgroup><tbody class="xRowGroup"><tr><td><span class="content_span">15-Oct-2024 12:01</span></td><td/><td/></tr><tr ID="_9034e1d8-aec0-4a06-86c0-82a9d8e3be83"><td/><td><content><span class="xSecondary">Oxygen delivery devices: </span><span class="xSecondary"/></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">Simple mask</span></td></tr></tbody><tbody class="xRowGroup"><tr><td><span class="content_span">15-Oct-2024 09:49</span></td><td/><td/></tr><tr ID="_e1fc35ff-d2e8-419b-bdc0-96ae06f722bf"><td/><td><content><span class="xSecondary">Weight </span><span class="xSecondary">72.2</span><span class="xSecondary"> kg </span></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">72.200</span></td></tr></tbody><tbody class="xRowGroup"><tr><td><span class="content_span">11-Oct-2024 10:15</span></td><td/><td/></tr><tr ID="_fb92da3d-3933-4c01-bf2e-f33f910d71ad"><td/><td><content><span class="xSecondary">Height </span><span class="xSecondary">4.75</span><span class="xSecondary"> [ft_us] </span></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">4</span></td></tr><tr ID="_df0b4271-519d-4d3e-be50-a2a621b931d2"><td/><td><content><span class="xSecondary">Weight </span><span class="xSecondary">79.5</span><span class="xSecondary"> kg </span></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">79.500</span></td></tr></tbody><tbody class="xRowGroup"><tr><td><span class="content_span">27-May-2024 12:20</span></td><td/><td/></tr><tr ID="_34caa0a5-abc4-4839-a3ec-92b1f8f44608"><td/><td><content><span class="xSecondary">BP Systolic </span><span class="xSecondary">122</span><span class="xSecondary"> mm[Hg] </span></content></td><td/></tr><tr ID="_7d635b3d-a8ce-443f-be99-083af1214779"><td/><td><content><span class="xSecondary">BP Diastolic </span><span class="xSecondary">82</span><span class="xSecondary"> mm[Hg] </span></content></td><td/></tr><tr ID="_341022e0-030d-4603-8fd2-253e5dbb8117"><td/><td><content><span class="xSecondary">Pulse </span><span class="xSecondary">95</span><span class="xSecondary"> {beats}/min </span></content></td><td/></tr><tr ID="_caafb92e-e465-4485-8c72-d54a4e262c52"><td/><td><content><span class="xSecondary">Temperature </span><span class="xSecondary">98</span><span class="xSecondary"> f </span></content></td><td/></tr><tr ID="_e3f3a504-c881-4812-bd87-0c9ddd4bf75a"><td/><td><content><span class="xSecondary">O2 SAT </span><span class="xSecondary">95</span><span class="xSecondary"> % </span></content></td><td/></tr><tr ID="_91cdb9f3-9a54-4102-91f7-cf03950b1bb3"><td/><td><content><span class="xSecondary">BMI </span><span class="xSecondary">29.3</span><span class="xSecondary"> kg/m2 </span></content></td><td/></tr><tr ID="_edf74d37-5ab8-4926-970b-b314f931807d"><td/><td><content><span class="xSecondary">Height </span><span class="xSecondary">60</span><span class="xSecondary"> in </span></content></td><td/></tr><tr ID="_6bbd618f-b96e-4338-8dcb-61b97d73c421"><td/><td><content><span class="xSecondary">Weight </span><span class="xSecondary">150</span><span class="xSecondary"> lb </span></content></td><td/></tr></tbody><tbody class="xRowGroup"><tr><td><span class="content_span">27-May-2024 12:20</span></td><td/><td/></tr><tr ID="_d49807fc-b249-46b5-a361-cdd09c65955f"><td/><td><content><span class="xSecondary">BP Systolic </span><span class="xSecondary">122</span><span class="xSecondary"> mm[Hg] </span></content></td><td/></tr><tr ID="_ff1e5612-1821-463e-ac04-d9a1adca551a"><td/><td><content><span class="xSecondary">BP Diastolic </span><span class="xSecondary">82</span><span class="xSecondary"> mm[Hg] </span></content></td><td/></tr><tr ID="_120c134a-fa9d-4e25-b96c-c4b70f385520"><td/><td><content><span class="xSecondary">Pulse </span><span class="xSecondary">95</span><span class="xSecondary"> {beats}/min </span></content></td><td/></tr><tr ID="_4a5f5c4c-82f9-4170-b784-be6104780e29"><td/><td><content><span class="xSecondary">Temperature </span><span class="xSecondary">98</span><span class="xSecondary"> f </span></content></td><td/></tr><tr ID="_2dbd0f01-f1fa-4d34-8a76-79a15c06ad06"><td/><td><content><span class="xSecondary">O2 SAT </span><span class="xSecondary">95</span><span class="xSecondary"> % </span></content></td><td/></tr><tr ID="_bf1e48e3-f21a-496a-a47d-aa247e919a7a"><td/><td><content><span class="xSecondary">BMI </span><span class="xSecondary">29.3</span><span class="xSecondary"> kg/m2 </span></content></td><td/></tr><tr ID="_f47b30fb-8cea-457c-8c5a-094b76a82441"><td/><td><content><span class="xSecondary">Height </span><span class="xSecondary">60</span><span class="xSecondary"> in </span></content></td><td/></tr><tr ID="_5118c59d-3ed4-43f5-91e0-c47fb4f1a8fb"><td/><td><content><span class="xSecondary">Weight </span><span class="xSecondary">150</span><span class="xSecondary"> lb </span></content></td><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Encounters</a></h3><div><table><colgroup><col width="40%"/><col width="20%"/><col width="40%"/></colgroup><tbody class="xRowGroup"><tr ID="_4cdc6161-2629-491b-b237-b3826099601c"><td><span class="content_span">short stay</span><br/><content><span class="xLabel xSecondary">Encounter Reason:</span><span class="xSecondary">FECAL INCONTINENCE</span></content><br/><content><span class="xSecondary xLabel">Encounter Diagnosis:</span><span class="xSecondary">Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span><span class="xSecondary">, </span><span class="xSecondary">Stage 3a chronic kidney disease</span><span class="xSecondary">, </span><span class="xSecondary">Chronic diastolic (congestive) heart failure</span><span class="xSecondary">, </span><span class="xSecondary">Anemia in chronic kidney disease</span><span class="xSecondary">, </span><span class="xSecondary">Paroxysmal atrial fibrillation</span><span class="xSecondary">, </span><span class="xSecondary">Hyperlipidemia, unspecified</span><span class="xSecondary">, </span><span class="xSecondary">Obesity, unspecified</span><span class="xSecondary">, </span><span class="xSecondary">Body mass index (BMI) 31.0-31.9, adult</span><span class="xSecondary">, </span><span class="xSecondary">Long term (current) use of anticoagulants</span><span class="xSecondary">, </span><span class="xSecondary">Hormone replacement therapy</span><span class="xSecondary">, </span><span class="xSecondary">Full incontinence of feces</span></content></td><td><span class="xSecondary">15-Oct-2024 07:44 </span><span class="xLabel xSecondary"> To </span><span class="xSecondary">15-Oct-2024 14:30</span><br/><span class="xSecondary">Szomstein Marcos X MD (Attending)</span><br/><span class="xSecondary">Mercy Hospital</span><br/></td><td><span class="xLabel">Discharge Disposition: </span><span class="xSecondary">Discharged to home or self care (routine discharge)</span><br/></td></tr><tr ID="_93ff58e1-4bcd-435a-b76a-87b4cc31f210"><td colspan="3"><span class="xIndent"> •</span><content class="xSecondary xContentWrapping"><span class="content_span">Szomstein Marcos X MD</span><span class="xLabel"> - </span><span class="content_span">15-Oct-2024</span><br/><span class="content_span">
HCA FLORIDA MERCY HOSPITAL (COCMHB)
Operative Report
REPORT#:           REPORT STATUS:
DATE:10/15/24 TIME: 1219

PATIENT: ROMAN,LUCIA                    UNIT #:
ACCOUNT#: D61011827508                  ROOM #:         BED:
DOB: 11/04/47  AGE: 76      SEX: F      ATTEND: Szomstein,Marcos X  MD
ADM DT: 10/15/24                        AUTHOR: Szomstein,Marcos X  MD

****************************ATTENTION**********************************
*EDITS and/or ADDENDA must be made in Patient Keeper for this note.   *
*      Edits and ammendments created in MEDITECH are not visible      *
*          in Patient Keeper or the legal medical record (HPF).       *
***********************************************************************

Note Date: 10/15/24 12:19

-- OPERATION --

SURGERY START DATE/TIME 10/15/2024 12:20

PRE-OPERATIVE DIAGNOSIS:
 fecal incontinence

POST-OPERATIVE DIAGNOSIS:
 fecal incontinence

INDICATION(S):
 fecal incontinence

NAME OF PROCEDURE:
 removal of old  stimulator and  implantation of sacral nerve stimulator stage
I and 2

Time out completed:: Yes
Surgeon:Szomstein, Marcos X  MD
ASSISTANT(S):
 surgical assistant

ANESTHESIA:
 IV sedation and local

ESTIMATED BLOOD LOSS 5 mls

FINDINGS:
 old  sacralnerve stimulator receiver and lead

SPECIMENS(S) REMOVED AND/OR ALTERED:
  sacral nerve stimulator

COMPLICATION(S):
 none

DISPOSITION:
 home


-- DESCRIPTION --


DESCRIPTION OF TECHNIQUE/PROCEDURE:
Indication for Surgery
76-year-old female with history of fecal incontinence. Patient had a sacral
nerve stimulator placed many years ago.    It stop  working a couple years ago.
 Also the area where it is it bothers the patient.  Also the patient was to
have a new device that is MRI compatible just in case she needs an MRI of her
back. Patient was taken to the operating room for  removal of old sacral nerve
stimulator and placement of new InterStim phase 1 and 2. Procedure and risks
discussed with the patient including bleeding, infection, fistula, stenosis,
incontinence, recurrence, abscesses, thrombosis, hernia, pulmonary emboli,
myocardial function, and death.

Description of Operative Procedure
The patient was taken to the operating room and after positive identification
IV sedation was administrated. The patient was placed in prone position in the
operating table. Pillows were placed under the lower abdomen to flatten the
sacrum. The C arm was draped and moved into AP position to provide fluoroscopic
mapping of the sacral region which included marking out the midline of the
sacrum, SI joints, sciatic notches, medial foraminal borders and sacral
foramina. The C arm was moved to lateral position to image the area from sacral
promontory to the coccyx. Local injection of 1% lidocaine was administered
administer. 1st we proceeded to remove the old receiver.  The old pocket was
opened.  Subcutaneous dissection was done down to the capsule.  The capsule was
calcified.  We excised all the capsule.  We removed the receiver and sent to
pathology.  We follow the track of the lead immuno counter incision on the
close to the midline.  We found the lead and removed the lead completely from
the sacrum.  This was done under direct vision.  The lid was intact.  Then we
proceeded to place the new sacral nerve stimulator stage I and 2. A 20-gauge
size foraminal needle was introduced approximately 2 cm above the sciatic notch
and 2 cm lateral to sacrum midline. We were feeling for foraminal margins until
the S3 foramen was identified and penetrated. The depth of the needle was
confirmed and adjusted fluoroscopically. Proper needle position was confirmed
by patient identification of location of sensation, direct observation of the
lifting of the perineum or Bellows, and observation of plantar flexion of the
great toe utilizing the external test stimulator. Then we used same technique
to access the left lateral sacral midline and tested in same fashion through
the right S3 foramina. We decided that the right side seemed to have a better
response and we chose the right side for the lead placement.

The foramen needle stylet was removed and directional guide was placed and
confirmed fluoroscopically. The foramen needle was removed. An incision was
made the referral to the directional guide through the fascial layer. The lead
introducer sheath with dilator was placed over the directional guide and
directed into the foramina ensuring the radiopaque marker of the lead
introducer did not extend beyond the anterior edge of the sacrum. The dilator
was unlocked and removed along with directional guide.The lead was then placed
through the introducer sheath to the first white line. Position was checked
fluoroscopically. The lead was then further introduced until 3 electrodes were
visible below the sacrum. Each electrode was tested for location of patient
sensation, visualization of Bellows, and plantarflexion of the great toe. After
satisfactory position was confirmed the introducer thickness was retracted
under continuous fluoroscopic control in the anterior leads lie into the
presacral tissue.

Another incision was made to create a subcutaneous pocket. I dissected into the
subcutaneous tissue posterior to the iliac crest and lateral to the sacrum.
Blunt dissection was done until the gluteal fascia was identified and
hemostasis was achieved. A tunneling tool was placed from the lead exit site
subcutaneously to the pocket site. The tunneling tool was removed and the lead

was fed through the straw and pulled out of the pocket site. The leg was
cleansed of bodily fluids and dried. The lead was completely dry. The normal
receiver was connected to the lead and it was tightened with a hex wrench over
the single screw. The receiver was placed on the pocket. The Medtronic rep
tested the device and it was working fine. The wound was irrigated with
antibiotic solution and water and closed with 3-0 Vicryl stitches for the
subcutaneous tissue and 4-0 Monocryl in a subcuticular fashion for the skin.
Dermabond was placed on top of the skin. Needle, instrument and sponges count
was correct  --2. The patient tolerated toward the procedure went out to the
recovery area in a stable condition. [1]




Electronically signed by Szomstein, Marcos X  MD  on 10/15/24 at 12:32



Electronically Signed by Marcos X Szomstein, MD on 10/15/24 at 1232
****************************ATTENTION**********************************
*EDITS and/or ADDENDA must be made in Patient Keeper for this note.   *
*      Edits and ammendments created in MEDITECH are not visible      *
*          in Patient Keeper or the legal medical record (HPF).       *
***********************************************************************
RPT #: 1015-0028
***END OF REPORT***</span></content></td></tr></tbody><tbody class="xRowGroup"><tr ID="_5b63df5f-329a-4a8a-ab2c-58c6c824541c"><td><span class="content_span">Ambulatory</span><br/><content><span class="xSecondary xLabel">Encounter Diagnosis:</span><span class="xSecondary">Exposure to SARS-CoV-2</span><span class="xSecondary">, </span><span class="xSecondary">Acute pharyngitis</span><span class="xSecondary">, </span><span class="xSecondary">Acute bronchitis</span></content></td><td><span class="xSecondary">27-May-2024 </span><br/><span class="xSecondary">MIGUEL RODRIGUEZ GARCIA (Attending)</span><br/><span class="xSecondary">West Flagler</span><br/></td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Plan of Treatment</a></h3><div>Plan of treatment may be documented in an alternate section</div><h3><a name="id10" href="#toc">Health Concerns</a></h3><div>Health concerns may be documented in an alternate section</div><h3><a name="id11" href="#toc">Goals</a></h3><div>Goals may be documented in an alternate section</div><h3><a name="id12" href="#toc">Assessments</a></h3><div>No assessment information available</div><h3><a name="id13" href="#toc">Medical Equipment</a></h3><div>No implantable device information available</div><br/><br/></body></html>